Evaluation of the Effect of Postoperative Analgesia Techniques With ObsQoR-10
Launched by ESKISEHIR OSMANGAZI UNIVERSITY · May 11, 2025
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is designed to study how different pain relief methods affect recovery in women who have an elective cesarean section. The researchers will compare two techniques: a transversus abdominis plane (TAP) block, which is an injection to numb the abdominal area, and wound infiltration, where pain relievers are injected directly into the surgical site. They will use a questionnaire called the Obstetric Quality of Recovery-10 (ObsQoR-10) to understand how well patients recover from surgery. Additionally, the study will look at pain levels, the amount of medication needed for pain relief, and any side effects like nausea or itching during the first 24 hours after surgery.
To participate in this trial, women between the ages of 18 and 50 who are having a planned cesarean section under spinal anesthesia may be eligible. However, those who have had general anesthesia, need an emergency cesarean section, or have certain medical conditions, such as bleeding disorders or infections at the injection site, will not be able to join. This study is not yet recruiting participants, but it aims to help improve pain management and recovery experiences for future mothers undergoing cesarean deliveries.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Term obstetric patients aged 18-50 years who underwent elective cesarean section under spinal anesthesia and applied regional anesthesia techniques such as TAP and wound infiltration.
- Exclusion Criteria:
- • Refuse to participate in the study
- • Patients who have undergone general anesthesia
- • Patients requiring emergency cesarean section.
- • Mental status disorders
- • Known bleeding and/or coagulation disorders
- • Infection at injection site
About Eskisehir Osmangazi University
Eskisehir Osmangazi University is a distinguished academic institution dedicated to advancing medical research and education. With a commitment to enhancing healthcare outcomes, the university actively sponsors clinical trials that explore innovative therapeutic approaches and contribute to the scientific community. Leveraging its state-of-the-art facilities and a team of experienced researchers, Eskisehir Osmangazi University fosters collaboration across disciplines to address pressing health challenges and improve patient care. Through its rigorous research initiatives, the university aims to translate findings into practical applications that benefit both local and global populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Eskisehir, Eski̇şehi̇r, Turkey
Eskisehir, , Turkey
Patients applied
Trial Officials
Meryem Onay
Principal Investigator
Eskisehir Osmangazi University Faculty Of Medıcıne
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported